Literature DB >> 8207409

Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody.

A Mabondzo1, F Boussin, H Raoul, R Le Naour, G Gras, B Vaslin, J Bartholeyns, J L Romet-Lemonne, D Dormont.   

Abstract

Human monocytes/macrophages, which express Fc receptors for IgG are involved in human immunodeficiency virus type 1 (HIV-1) infection and pathogenesis. These receptors are known to mediate numerous immunological functions including cell-mediated killing and possibly targeting of HIV to the lysophagosome monocyte-derived macrophage (MDM) entry route for virus neutralization. To study both activities in HIV-1 infection, MDM Fc gamma RI was specifically selected using bispecific antibody (Bs-Ab) containing whole human monoclonal antibody against gp41 and the Fab' fragment of murine anti-Fc gamma RI 22.2 antibody. Bs-Ab was found to mediate potent antibody-dependent cellular cytotoxicity and virus neutralization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207409     DOI: 10.1099/0022-1317-75-6-1451

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

Review 1.  HIV antibodies for treatment of HIV infection.

Authors:  David M Margolis; Richard A Koup; Guido Ferrari
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

2.  Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages.

Authors:  D Blond; H Raoul; R Le Grand; D Dormont
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection.

Authors:  O Alsmadi; R Herz; E Murphy; A Pinter; S A Tilley
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 4.  Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection.

Authors:  Guido Ferrari; Barton F Haynes; Scott Koenig; Jeffrey L Nordstrom; David M Margolis; Georgia D Tomaras
Journal:  Nat Rev Drug Discov       Date:  2016-10-07       Impact factor: 84.694

5.  Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

Authors:  A Mabondzo; P Rouvier; H Raoul; R Le Naour; C Courpotin; F Hervé; F Parnet-Mathieu; G Lasfargues; D Dormont
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 6.  Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.

Authors:  Deborah J Anderson; Joseph A Politch; Larry Zeitlin; Andy Hiatt; Kadryn Kadasia; Kenneth H Mayer; Ruth M Ruprecht; Francois Villinger; Kevin J Whaley
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.632

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.